Stay updated with breaking news from Actinium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) has entered into a research collaboration with Columbia University to study Actimab-A, its clinical-stage CD33 targeting radiotherapeutic
NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, and Eckert
The International Centers for Precision Oncology (ICPO) Foundation is pleased to announce that its first Maurits W. Geerlings Next Generation Award presentation for Outstanding Research and Contributions
BRUSSELS (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM), a developer of targeted radiotherapies, announced Tuesday that it has entered into a license and supply agreement with Immedica Pharma
Actinium (ACM) traded down 1.8% against the US dollar during the 1-day period ending at 17:00 PM Eastern on April 10th. Over the last seven days, Actinium has traded 3.6% higher against the US dollar. Actinium has a total market capitalization of $635,538.05 and $22,542.00 worth of Actinium was traded on exchanges in the last […]